Mr. Speaker, several questions were asked on the floor of the House yesterday. This issue has been raised by a number of groups, NGOs, pharmaceutical companies, and a number of them have asked to testify before the parliamentary committee, which would be prepared to grant such a request.
A number of members on all sides of the House and I have had discussions today, and we certainly are prepared to have second reading go through today and to allow witnesses who want to appear before committee to be heard.